<DOC>
	<DOCNO>NCT01047501</DOCNO>
	<brief_summary>The primary objective determine efficacy AMR101 ( ethyl icosapentate ) compare placebo lower high fast triglyceride level patient high risk cardiovascular disease fast triglyceride level ≥ 200 &lt; 500 mg/dL .</brief_summary>
	<brief_title>Effect AMR101 ( Ethyl Icosapentate ) Triglyceride ( Tg ) Levels Patients Statins With High Tg Levels ( ≥ 200 &lt; 500 mg/dL )</brief_title>
	<detailed_description />
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<mesh_term>Eicosapentaenoic acid ethyl ester</mesh_term>
	<criteria>Men woman , age &gt; 18 Fasting triglyceride ≥200 mg/dL &lt; 500 mg/dL LDLC ( low density lipoprotein cholesterol ) ≥40 mg/dL &lt; 100mg/dL High risk Coronary heart disease On stable dose statin ( atorvastatin , rosuvastatin simvastatin ) Provide write informed consent authorization protect health information disclosure Women pregnant lactating , plan become pregnant Use nonstatin lipidaltering drug stop include fibrates , niacin , fish oil product contain omega3 fatty acid dietary supplement potential lipidaltering effect History bariatric surgery currently weight loss drug Uncontrolled hypertension ( BP &gt; 160/100 ) HIV infection treatment HIVprotease inhibitor , cyclophosphamide , isotretinoin Consumption 2 alcoholic beverage per day History cancer ( except disease free &gt; 5 year OR history basal squamous cell skin cancer ) Participation another clinical trial involve investigational agent last 30 day Other parameter assess study center ensure eligibility study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>hypertriglyceridemia</keyword>
	<keyword>omega-3 fatty acid</keyword>
	<keyword>statin</keyword>
	<keyword>triglyceride</keyword>
	<keyword>lipid</keyword>
	<keyword>EPA</keyword>
	<keyword>docosahexaenoic acid</keyword>
	<keyword>fish</keyword>
	<keyword>fatty acid</keyword>
	<keyword>fibrates</keyword>
	<keyword>niacin</keyword>
	<keyword>lipid</keyword>
	<keyword>atorvastatin</keyword>
	<keyword>Lovaza</keyword>
	<keyword>simvastatin</keyword>
	<keyword>lovastatin</keyword>
	<keyword>pravastatin</keyword>
	<keyword>fluvastatin</keyword>
	<keyword>rosuvastatin</keyword>
	<keyword>Trilipix</keyword>
	<keyword>Vytorin</keyword>
	<keyword>Simcor</keyword>
	<keyword>Niaspan</keyword>
	<keyword>ezetimibe</keyword>
	<keyword>Zetia</keyword>
	<keyword>ethyl-EPA</keyword>
	<keyword>ethyl icosapentate</keyword>
	<keyword>Crestor</keyword>
	<keyword>Zocor</keyword>
	<keyword>Lipitor</keyword>
	<keyword>LDL</keyword>
	<keyword>HDL</keyword>
	<keyword>cholesterol</keyword>
	<keyword>dyslipidemia</keyword>
	<keyword>VASCEPA</keyword>
	<keyword>icosapent ethyl</keyword>
</DOC>